Ten Million Dead by 2050: How Antibiotics Are Losing Control
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
Antibiotics once turned routine infections into minor setbacks; today researchers project ten million deaths per year from drug-resistant infections by 2050. Ordinary acts-a prescription, a farmer adding powder to a trough, a patient stopping pills early-have multiplied into a global selection engine for resistant bacteria; can the erosion of modern medicine be stopped in time?
In this episode, we lay out how the discovery of penicillin in 1928 and its rapid development in the 1940s rewired medicine, why the antibiotic pipeline slowed while resistance accelerated, and where resistant organisms are already spreading through hospitals, farms, water and food-what will it take to slow or reverse that trend?
Person: Alexander Fleming
Date: 1928
Event: Discovery of Penicillium notatum antibacterial effect
Period: 1940s-1960s antibiotic expansion
Projection: Ten million annual deaths by 2050
- Fleming observed a mold killing bacteria on a petri dish in 1928.
- Penicillin was developed into a usable medicine by a team at Oxford during the Second World War.
- Life expectancy rose and surgeries became routine after widespread antibiotic use in the 1940s-1960s.
- Pharmaceutical antibiotic development slowed by the late twentieth century due to unfavorable economics and complex regulation.
- A UK study found three days of amoxicillin produced the same recovery for pneumonia as seven days, suggesting longer courses can be unnecessary.
To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.
© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません